Share

March 06, 2018; 90 (10) Editorial

Maternal and fetal risks of natalizumab exposure in utero

A fine balance

Ruth Ann Marrie
First published February 7, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005075
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
169

Share

Article Information

vol. 90 no. 10 443-444
DOI: 
https://doi.org/10.1212/WNL.0000000000005075
PubMed: 
29438040
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 7, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Ruth Ann Marrie, MD, PhD
  1. Ruth Ann Marrie, MD, PhD
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology, Editorial Board Multiple Sclerosis Journal, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Received support as site Principal Investigator for clinical trials from Sanofi- Aventis (2007-2015)

    Research Support, Government Entities:

    1. Received support as principal investigator from the Canadian Institutes of Health Research (2010-2019), and Research Manitoba (2014-2019).

    Research Support, Academic Entities:

    1. Waugh Family Chair in Multiple Sclerosis

    Research Support, Foundations and Societies:

    1. Received support as principal investigator from Multiple Sclerosis Society of Canada (2009-2016) and the National Multiple Sclerosis Society (2013-2017), and as co-principal investigator from Multiple Sclerosis Scientific Foundation (2009-2018). Received support from Consortium of Multiple Sclerosis Centers (2004-2009, 2011-2014, 2016-2017), Rx & D Health Research Foundation (2010-2015), Crohn's and Colitis Canada (2014- 2019)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Canada.
  1. Correspondence
    Dr. Marrie rmarrie{at}exchange.hsc.mb.ca
View Full Text

Article usage

Article usage: February 2018 to April 2022

AbstractFullPdfSource
Feb 2018317035Highwire
Mar 20183849562Highwire
Apr 2018661117Highwire
May 20188144Highwire
Jun 20184525Highwire
Jul 20185727Highwire
Aug 20183201Highwire
Sep 20182403Highwire
Oct 20182810Highwire
Nov 20182622Highwire
Dec 20184102Highwire
Jan 20195325Highwire
Feb 20193213Highwire
Mar 20193132Highwire
Apr 20192031Highwire
May 20192800Highwire
Jun 20192211Highwire
Jul 20193055Highwire
Aug 20192222Highwire
Sep 20192711Highwire
Oct 20192201Highwire
Nov 20193021Highwire
Dec 20192900Highwire
Jan 20202510Highwire
Feb 20202010Highwire
Mar 20201132Highwire
Apr 2020300Highwire
May 2020510Highwire
Jun 2020931Highwire
Jul 2020800Highwire
Aug 2020510Highwire
Sep 20202921Highwire
Oct 20201601Highwire
Nov 20201441Highwire
Dec 20202800Highwire
Jan 2021900Highwire
Feb 20212000Highwire
Mar 20211100Highwire
Apr 20214400Highwire
May 20211723Highwire
Jun 2021700Highwire
Jul 20211400Highwire
Aug 20211100Highwire
Sep 20211300Highwire
Oct 20211700Highwire
Nov 2021900Highwire
Dec 2021900Highwire
Jan 20221000Highwire
Feb 20222500Highwire
Mar 20222100Highwire
Apr 20221600Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me